Launched KOMZIFTI™ (ziftomenib), first and only once-daily, oral menin inhibitor approved for adults with R/R NPM1-mutated ...

Collaborating institutions in Taiwan report higher risks of atopic disease among children conceived via assisted reproductive ...

In our case, a second ultrasound with the “ultrasound” Shibangu test was performed and revealed that the pregnancy was ...

Among the books hitting shelves this week and next are a picture book about an Indigenous community collaborating on a ...

Back in 2017, when my husband was still in the Army, we learned he was unexpectedly deploying right as we were going to start trying to get pregnant. Military families get accustomed to this pattern: ...

More than 73 million abortions were performed worldwide in 2025, making abortion the leading cause of death last year. The ...

More than 73 million abortions were performed worldwide in 2025, making abortion the leading cause of death last year The figure draws on World Health Organization estimates compiled by the global ...

Partner Therapeutics, Inc. (PTx), a private, fully integrated biotechnology company, announced new data from a post hoc analysis of the eNRGy trial (NCT02912949), evaluating zenocutuzumab in patients ...

As she told PEOPLE, "an outside [surrogate], however close, might have wanted to keep the babies, and that would have been ...

Presenter Erin Holland opens up about her unconventional long-distance marriage and navigating a “rollercoaster” four-year ...

Pfizer Inc. today announced positive results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, ...

Program will expand access in certain regions where Revuforj is not available commercially, as permitted by local regulations -- Program will ...